Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS.

Literature DB >> 33633686

Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS.

Abstract

Since the historical use of gonadotrophin and estradiol levels to define the different anovulatory disorders has shown some limitations, the use of other markers such as anti-müllerian hormone (AMH) has been proposed. This review addresses the role of AMH in the differential diagnosis of anovulatory disorders, especially focusing on its value in the prognostic characterization of their severity. Current limitations and future clinical applications are discussed.

Entities: Chemical Disease Gene Species

Keywords: amenorrhea; anovulatory disorders; anti-Müllerian hormone; polycystic ovary syndrome; premature ovarian insufficiency

Mesh：

Substances：
Anti-Mullerian Hormone

Year: 2021 PMID： 33633686 PMCID： PMC7901963 DOI： 10.3389/fendo.2020.616766

Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN： 1664-2392 Impact factor: 5.555

53 in total

Review 1. Anti-Müllerian hormone and folliculogenesis.

Authors: Jenny A Visser; Axel P N Themmen
Journal: Mol Cell Endocrinol Date: 2005-04-29 Impact factor: 4.102

Review 2. Long-term health consequences of premature or early menopause and considerations for management.

Authors: S S Faubion; C L Kuhle; L T Shuster; W A Rocca
Journal: Climacteric Date: 2015-04-07 Impact factor: 3.005

3. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells.

Authors: Laura Pellatt; Suman Rice; Nafi Dilaver; Amira Heshri; Raymond Galea; Mark Brincat; Kristy Brown; Evan R Simpson; Helen D Mason
Journal: Fertil Steril Date: 2011-09-13 Impact factor: 7.329

4. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Authors: Terhi Piltonen; Laure Morin-Papunen; Riitta Koivunen; Antti Perheentupa; Aimo Ruokonen; Juha S Tapanainen
Journal: Hum Reprod Date: 2005-03-31 Impact factor: 6.918

5. Predictors of recovery of ovarian function during weight gain in anorexia nervosa.

Authors: Annemarie A van Elburg; Marinus J C Eijkemans; Martien J H Kas; Axel P N Themmen; Frank H de Jong; Herman van Engeland; Bart C J M Fauser
Journal: Fertil Steril Date: 2007-01-18 Impact factor: 7.329

6. The role of AMH in anovulation associated with PCOS: a hypothesis.

Authors: Roy Homburg; Giselle Crawford
Journal: Hum Reprod Date: 2014-04-25 Impact factor: 6.918

Review 7. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors:
Journal: Hum Reprod Date: 2004-01 Impact factor: 6.918

8. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.

Authors: M P Lauritsen; J G Bentzen; A Pinborg; A Loft; J L Forman; L L Thuesen; A Cohen; D M Hougaard; A Nyboe Andersen
Journal: Hum Reprod Date: 2014-01-16 Impact factor: 6.918